Abstract:Chemical proteomics is an emerging technique for drug target deconvolution and profiling the toxicity of known drugs. With the use of this technique, the specificity of a small molecule inhibitor toward its potential targets can be characterized and information thus obtained can be used in optimizing lead compounds. Most commonly, small molecules are immobilized on solid supports and used as affinity chromatography resins to bind targets. However, it is difficult to evaluate the effect of immobilization on the affinity of the compounds to their targets. Here, we describe the development and application of a soluble probe where a small molecule was coupled with a peptide epitope which was used to affinity isolate binding proteins from cell lysate. The soluble probe allowed direct verification that the compound after coupling with peptide epitope retained its binding characteristics. The PKC-alpha inhibitor Bisindolylmaleimide-III was coupled with a peptide containing the FLAG epitope. Following incubation with cellular lysates, the compound and associated proteins were affinity isolated using anti-FLAG antibody beads. Using this approach, we identified the known Bisindolylmaleimide-III targets, PKC-alpha, GSK3-beta, CaMKII, adenosine kinase, CDK2, and quinine reductase type 2, as well as previously unidentified targets PKAC-alpha, prohibitin, VDAC and heme binding proteins. This method was directly compared to the solid-phase method (small molecule was immobilized to a solid support) providing an orthogonal strategy to aid in target deconvolution and help to eliminate false positives originating from nonspecific binding of the proteins to the matrix.

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.

Methods to Profile the Macromolecular Targets of Small Compounds.

Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes.

Chemical Proteomics to Identify Molecular Targets of Small Compounds

An immuno-chemo-proteomics method for drug target deconvolution

Exploiting Chemical Probes for Identifying Drug Target Proteins

Enhanced mapping of small-molecule binding sites in cells

Proteome interrogation using nanoprobes to identify targets of a cancer-killing molecule.

Chemical proteomic mapping of reversible small molecule binding sites in native systems

STREAMLINED PROTEOME-WIDE IDENTIFICATION OF DRUG TARGETS INDICATES ORGAN-SPECIFIC ENGAGEMENT

[The Application of Small Molecule Bioactive Probes in the Identification of Cellular Targets].

Expression proteomics reveals protein targets and highlights mechanisms of action of small molecule drugs

CellEKT: A robust chemical proteomics workflow to profile cellular target engagement of kinase inhibitors

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

Tetrazole-Based Probes for Integrated Phenotypic Screening, Affinity-Based Proteome Profiling, and Sensitive Detection of a Cancer Biomarker.

Label-free target protein characterization for small molecule drugs: recent advances in methods and applications

Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles

An unbiased immunoaffinity-based strategy for profiling covalent drug targets in vivo.

Proteomic methods for drug target discovery

Proteome-wide discovery and characterizations of nucleotide-binding proteins with affinity-labeled chemical probes.